Press release
Advanced Cancer Pain Management Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Avalo Therapeutics Inc., Zynerba Pharmaceuticals Inc., Nobias Therapeutics,Inc., Enzyvant Therapeutics GmBH, Natera Inc
Advanced Cancer Pain Management Market
Discover which therapies are expected to grab the Advanced Cancer Pain Management Market Share @ Advanced Cancer Pain Management Market Outlook- https://www.delveinsight.com/sample-request/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Advanced Cancer Pain Management Market Report
• In a study by Jiang et al. (2019), of the identified 4526 cancer survivors, 1648 reported having chronic pain and 768 reported having HICP, representing approximately 5.39 million and 2.51 million cancer survivors, respectively, in the US population.
• In a study by Everdingen et al. (2016), pain prevalence rates were 39.3% after curative treatment; 55.0% during anticancer treatment; and 66.4% in advanced, metastatic, or terminal disease. Moderate to severe pain was reported by 38.0% of all patients.
• In a study by Marieke et al. (2016), pain severity resulted in a 38.0% prevalence of moderate to severe pain. With reference to types of cancer, lower pain prevalence rates were demonstrated in prostate cancer compared to head and neck, lung, and breast cancer.
• In a study by Rustøen et al. (2013), high intensity of breakthrough cancer pain was described by 75.5% of the patients, and the painful crises can be exacerbated by either predictable or unpredictable events.The increase in Advanced Cancer Pain Management Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Advanced Cancer Pain Management Market is anticipated to witness growth at a considerable CAGR.
• The leading Advanced Cancer Pain Management Companies such as Avalo Therapeutics Inc., Zynerba Pharmaceuticals, Inc., Nobias Therapeutics, Inc., Enzyvant Therapeutics GmBH, Natera, Inc., and others.
• Promising Advanced Cancer Pain Management Pipeline Therapies such as Nabiximols, GA-0034, Sativex Low Dose and others.
Stay ahead in the Advanced Cancer Pain Management Therapeutics Market with DelveInsight's Strategic Report @ Advanced Cancer Pain Management Market Outlook- https://www.delveinsight.com/sample-request/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Advanced Cancer Pain Management Epidemiology Segmentation in the 7MM
The epidemiology section of Advanced Cancer Pain Management offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Advanced Cancer Pain Management Epidemiology trends @ Advanced Cancer Pain Management Prevalence- https://www.delveinsight.com/sample-request/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Advanced Cancer Pain Management Drugs Market
The Advanced Cancer Pain Management Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Advanced Cancer Pain Management signaling in Advanced Cancer Pain Management are likely to uncover new therapeutic targets and further expand treatment options for patients.
Advanced Cancer Pain Management Treatment Market Landscape
The Advanced Cancer Pain Management treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Advanced Cancer Pain Management has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Advanced Cancer Pain Management treatment guidelines, visit @ Advanced Cancer Pain Management Treatment Market Landscape- https://www.delveinsight.com/sample-request/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Advanced Cancer Pain Management Market Outlook
The report's outlook on the Advanced Cancer Pain Management market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Advanced Cancer Pain Management therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Advanced Cancer Pain Management drug and late-stage pipeline therapy.
Advanced Cancer Pain Management Drugs Uptake
The drug chapter of the Advanced Cancer Pain Management report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Advanced Cancer Pain Management.
Major Advanced Cancer Pain Management Companies
Avalo Therapeutics Inc., Zynerba Pharmaceuticals, Inc., Nobias Therapeutics, Inc., Enzyvant Therapeutics GmBH, Natera, Inc., and others.
Learn more about the FDA-approved drugs for Advanced Cancer Pain Management @ Drugs for Advanced Cancer Pain Management Treatment- https://www.delveinsight.com/sample-request/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Advanced Cancer Pain Management Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Advanced Cancer Pain Management Companies- Avalo Therapeutics Inc., Zynerba Pharmaceuticals, Inc., Nobias Therapeutics, Inc., Enzyvant Therapeutics GmBH, Natera, Inc., and others.
• Advanced Cancer Pain Management Pipeline Therapies- Nabiximols, GA-0034, Sativex Low Dose and others.
• Advanced Cancer Pain Management Market Dynamics: Advanced Cancer Pain Management Market Drivers and Barriers
• Advanced Cancer Pain Management Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Advanced Cancer Pain Management Drugs in development @ Advanced Cancer Pain Management Clinical Trials Assessment- https://www.delveinsight.com/sample-request/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Advanced Cancer Pain Management Executive Summary
3. Advanced Cancer Pain Management Competitive Intelligence Analysis
4. Advanced Cancer Pain Management: Market Overview at a Glance
5. Advanced Cancer Pain Management: Disease Background and Overview
6. Patient Journey
7. Advanced Cancer Pain Management Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Advanced Cancer Pain Management Unmet Needs
10. Key Endpoints of Advanced Cancer Pain Management Treatment
11. Advanced Cancer Pain Management Marketed Products
12. Advanced Cancer Pain Management Emerging Therapies
13. Advanced Cancer Pain Management: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Advanced Cancer Pain Management Market Outlook
16. Access and Reimbursement Overview of Advanced Cancer Pain Management
17. KOL Views
18. Advanced Cancer Pain Management Market Drivers
19. Advanced Cancer Pain Management Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2025
NK Cell Therapy Market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Psoriasis Vulgaris Market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Urea Cycle Disorders Market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Immune Checkpoints Activators Market- https://www.delveinsight.com/report-store/immune-checkpoint-inhibitors-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Surgical Robotic System Market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Diabetic Wound Market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Indwelling Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Overactive Bladder Syndrome Market- https://www.delveinsight.com/report-store/underactive-bladder-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Healthcare Competitive Benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Intraocular Lens Market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/blog/cardiac-monitoring-devices-market
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical Mask & Respirator Market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Bone Growth Stimulator Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Cancer Pain Management Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Avalo Therapeutics Inc., Zynerba Pharmaceuticals Inc., Nobias Therapeutics,Inc., Enzyvant Therapeutics GmBH, Natera Inc here
News-ID: 3963341 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
